| Labatec Pharma SA - Ovaleap 450 IU/0.75 ml, solution injectable |
| 66255 | | 02 | | Ovaleap 450 IU/0.75 ml | | solution injectable | | G03GA05 | | Follitropin alfa | | 28.08.2018 | | |
|
| Zusammensetzung |
| follitropinum alfa 450 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, methioninum, polysorbatum 20, alcohol benzylicus 7.5 mg, benzalkonii chloridum 0.015 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 7.7 mg. |
| Packungsbestandteile |
| Injektionslösung | | | | | | | | Wirkstoffe | Stärke |
|---|
| Follitropin Alfa | 450U.I. / 0.75ml |
| | BAG: Wirkstoffe | Stärke |
|---|
| Follitropin Alfa | 450 UI |
| | | | Hilfsstoffe | Stärke |
|---|
| Alcohol Benzylicus | 7.5mg / 0.75ml | | Benzalkonium Chlorid | 0.015mg / 0.75ml | | Mannitol | | | Methionin | | | Natrium Dihydrogenophosphat Dihydrat | | | Natrii Hydroxidum ad Ph | | | Polysorbatum 20 | |
| |
|
| Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 002 | | 138.12 | 166.65 | A | SL | Nein |
|
